Dallas Voice10h
FDA accepts Gilead’s new drug applications for lencapavir
Gilead pharmaceutical company announced today (Tuesday, Feb. 18) that the U.S. Food and Drug Administration has accepted the company’s  “new drug applications” for lencapavir, a twice-yearly ...
Hosted on MSN11h
NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight
Graphic processing units (GPUs) and artificial intelligence (AI) are among the most searched terms online these days, making companies like NVIDIA NVDA the focal point of investors’ interest. While ...
FDA approves tablet form of Evrysdi for spinal muscular atrophy
The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...
FDA staff reviewing Musk’s Neuralink were included in DOGE employee firings, sources say
U.S. Food and Drug Administration employees reviewing Elon Musk’s brain implant company Neuralink were fired over the weekend ...
Imagion to start production of MagSense imaging agent for phase II breast cancer trial
Imagion Biosystems has initiated manufacturing of its MagSense imaging agent for its phase II clinical study on HER2+ breast cancer, an essential requirement for filing an Investigational New Drug ...
Healio20h
FDA accepts IND for allogenic CAR T-cell therapy that could bypass lymphodepletion
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...